Paulo C. Gregório, Gilson Biagini, Regiane S. da Cunha, Júlia Budag, Ana Maria Martins, Lara Valiño Rivas, . . . Fellype C. Barreto. (2022). Growth Differentiation Factor-15 and Syndecan-1 Are Potential Biomarkers of Cardiac and Renal Involvement in Classical Fabry Disease under Enzyme Replacement Therapy. Karger Publishers.
Chicago Style (17th ed.) CitationPaulo C. Gregório, et al. Growth Differentiation Factor-15 and Syndecan-1 Are Potential Biomarkers of Cardiac and Renal Involvement in Classical Fabry Disease Under Enzyme Replacement Therapy. Karger Publishers, 2022.
MLA (9th ed.) CitationPaulo C. Gregório, et al. Growth Differentiation Factor-15 and Syndecan-1 Are Potential Biomarkers of Cardiac and Renal Involvement in Classical Fabry Disease Under Enzyme Replacement Therapy. Karger Publishers, 2022.